Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: ChemistInvestor who wrote (624)	8/9/2001 9:25:56 AM
From: Harold Engstrom	Read Replies (1) \| Respond to of 717

Why is it getting hard to ignore PCYC at these prices? Do you expect Xcytrin PIII results soon and expect they will fulfill positive expectations v. the claims that previous results have been unrepeatedable by third parties? I have owned PCYC profitably in the past, but each time it spiked I sold. I have not bought back in because it is unclear when the PIII will be completed and results unveiled. Although, it appears that more trials are planned. My fear is that PCYC becomes a company that is always focused on the next thing and does not bring anything to market. Why are you enthused?